4//SEC Filing
Leal James 4
Accession 0001438133-24-000097
CIK 0001438133other
Filed
May 16, 8:00 PM ET
Accepted
May 17, 5:46 PM ET
Size
26.0 KB
Accession
0001438133-24-000097
Insider Transaction Report
Form 4
Leal James
SVP, Operations
Transactions
- Award
Common Stock
2024-05-15$15.64/sh+590$9,228→ 11,406 total - Exercise/Conversion
Common Stock
2024-05-15+168→ 11,574 total - Tax Payment
Common Stock
2024-05-15$47.37/sh−70$3,316→ 11,504 total - Exercise/Conversion
Common Stock
2024-05-15+806→ 12,310 total - Tax Payment
Common Stock
2024-05-15$47.37/sh−334$15,822→ 11,976 total - Exercise/Conversion
Common Stock
2024-05-15+2,299→ 14,275 total - Tax Payment
Common Stock
2024-05-15$47.37/sh−951$45,049→ 13,324 total - Exercise/Conversion
Common Stock
2024-05-15+5,748→ 19,072 total - Tax Payment
Common Stock
2024-05-15$47.37/sh−2,377$112,598→ 16,695 total - Exercise/Conversion
Restricted Stock Unit
2024-05-15−168→ 670 total→ Common Stock (168 underlying) - Exercise/Conversion
Restricted Stock Unit
2024-05-15−806→ 3,223 total→ Common Stock (806 underlying) - Exercise/Conversion
Restricted Stock Unit
2024-05-15−2,299→ 4,599 total→ Common Stock (2,299 underlying) - Exercise/Conversion
Restricted Stock Unit
2024-05-15−5,748→ 11,497 total→ Common Stock (5,748 underlying)
Footnotes (11)
- [F1]The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of November 16, 2023 through May 15, 2024. This transaction is also exempt under Rule 16b-3(c).
- [F10]Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan).
- [F11]Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
- [F2]Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
- [F3]Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).
- [F4]Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.
- [F5]RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.
- [F6]Awarded on May 25, 2022 pursuant to the 2013 Plan.
- [F7]RSU vest as to thiry-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
- [F8]Awarded on May 15, 2023 pursuant to the 2013 Plan.
- [F9]RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
Documents
Issuer
TANDEM DIABETES CARE INC
CIK 0001438133
Entity typeother
Related Parties
1- filerCIK 0001866570
Filing Metadata
- Form type
- 4
- Filed
- May 16, 8:00 PM ET
- Accepted
- May 17, 5:46 PM ET
- Size
- 26.0 KB